US20130008852A1 - Urea sorbent - Google Patents
Urea sorbent Download PDFInfo
- Publication number
- US20130008852A1 US20130008852A1 US13/541,107 US201213541107A US2013008852A1 US 20130008852 A1 US20130008852 A1 US 20130008852A1 US 201213541107 A US201213541107 A US 201213541107A US 2013008852 A1 US2013008852 A1 US 2013008852A1
- Authority
- US
- United States
- Prior art keywords
- urea
- polymer
- dialysate
- water
- functional groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 *CC(*)O.*CC(*)OC(=O)C([H])=O.O.[H]C(=O)C(=O)O Chemical compound *CC(*)O.*CC(*)OC(=O)C([H])=O.O.[H]C(=O)C(=O)O 0.000 description 8
- NVXRAYJZTFQBMX-UHFFFAOYSA-N C.C.CCCCC(C)O.O.O=S(Cl)Cl.[H]C(=O)C(=O)Cl.[H]C(=O)C(=O)Cl.[H]C(=O)C(=O)O.[H]C(=O)C(=O)OC(C)CCCC Chemical compound C.C.CCCCC(C)O.O.O=S(Cl)Cl.[H]C(=O)C(=O)Cl.[H]C(=O)C(=O)Cl.[H]C(=O)C(=O)O.[H]C(=O)C(=O)OC(C)CCCC NVXRAYJZTFQBMX-UHFFFAOYSA-N 0.000 description 1
- WJYHGJYMRVCJMX-UHFFFAOYSA-N C.CC(=O)C(=O)O.CCCCC(C)O.CCCCC(C)OC(=O)C(C)=O Chemical compound C.CC(=O)C(=O)O.CCCCC(C)O.CCCCC(C)OC(=O)C(C)=O WJYHGJYMRVCJMX-UHFFFAOYSA-N 0.000 description 1
- WETBIEOFXJAAND-UHFFFAOYSA-N C.CCC(O)CC(C)OC(=O)C1=CC=CC=C1.O.[H]C(=O)C(=O)O.[H]C(=O)C(=O)OC(CC)CC(C)OC(=O)C1=CC=CC=C1 Chemical compound C.CCC(O)CC(C)OC(=O)C1=CC=CC=C1.O.[H]C(=O)C(=O)O.[H]C(=O)C(=O)OC(CC)CC(C)OC(=O)C1=CC=CC=C1 WETBIEOFXJAAND-UHFFFAOYSA-N 0.000 description 1
- DBECDYAYJRMLCW-UHFFFAOYSA-N C.CCCCC(C)O.O.[H]C(=O)C(=O)O.[H]C(=O)C(=O)OC(C)CCCC Chemical compound C.CCCCC(C)O.O.[H]C(=O)C(=O)O.[H]C(=O)C(=O)OC(C)CCCC DBECDYAYJRMLCW-UHFFFAOYSA-N 0.000 description 1
- MJEFPNNJPVQDRN-UHFFFAOYSA-N CC(C)N.CCC(C)C(=O)O.CCC(CC(C)C(=O)NC(C)C)C(=O)O Chemical compound CC(C)N.CCC(C)C(=O)O.CCC(CC(C)C(=O)NC(C)C)C(=O)O MJEFPNNJPVQDRN-UHFFFAOYSA-N 0.000 description 1
- UDVKFZBOVHJWTN-UHFFFAOYSA-N CCC(C)C(=O)O.CCC(C)O.CCC(C)OC(=O)C(C)CC(CC)C(=O)O Chemical compound CCC(C)C(=O)O.CCC(C)O.CCC(C)OC(=O)C(C)CC(CC)C(=O)O UDVKFZBOVHJWTN-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
- C08F8/14—Esterification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1694—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes with recirculating dialysing liquid
- A61M1/1696—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes with recirculating dialysing liquid with dialysate regeneration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
- B01J20/20—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising free carbon; comprising carbon obtained by carbonising processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/26—Synthetic macromolecular compounds
- B01J20/261—Synthetic macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/26—Synthetic macromolecular compounds
- B01J20/264—Synthetic macromolecular compounds derived from different types of monomers, e.g. linear or branched copolymers, block copolymers, graft copolymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/26—Synthetic macromolecular compounds
- B01J20/265—Synthetic macromolecular compounds modified or post-treated polymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28014—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their form
- B01J20/28052—Several layers of identical or different sorbents stacked in a housing, e.g. in a column
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J41/00—Anion exchange; Use of material as anion exchangers; Treatment of material for improving the anion exchange properties
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F216/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical
- C08F216/02—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical by an alcohol radical
- C08F216/04—Acyclic compounds
- C08F216/06—Polyvinyl alcohol ; Vinyl alcohol
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F218/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an acyloxy radical of a saturated carboxylic acid, of carbonic acid or of a haloformic acid
- C08F218/02—Esters of monocarboxylic acids
- C08F218/04—Vinyl esters
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F218/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an acyloxy radical of a saturated carboxylic acid, of carbonic acid or of a haloformic acid
- C08F218/02—Esters of monocarboxylic acids
- C08F218/04—Vinyl esters
- C08F218/10—Vinyl esters of monocarboxylic acids containing three or more carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
- C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
- C08F8/32—Introducing nitrogen atoms or nitrogen-containing groups by reaction with amines
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/04—Acids; Metal salts or ammonium salts thereof
- C08F220/06—Acrylic acid; Methacrylic acid; Metal salts or ammonium salts thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F2800/00—Copolymer characterised by the proportions of the comonomers expressed
- C08F2800/10—Copolymer characterised by the proportions of the comonomers expressed as molar percentages
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F2810/00—Chemical modification of a polymer
- C08F2810/20—Chemical modification of a polymer leading to a crosslinking, either explicitly or inherently
Definitions
- the following disclosure relates to sorbent materials for separating and/or removing urea from dialysate solutions in sorbent-based dialysis treatment or for separating and/or removing urea from aqueous solutions or liquids in medical related processes or circumstances.
- Hemodialysis is a process by which toxins and other molecules, such as urea, are removed from the blood using a semi-permeable filtering membrane.
- a semi-permeable filtering membrane typically, the patient's blood and an aqueous solution (i.e., dialysate) are pumped in counter-direction flows in and about hollow, semi-permeable fibers.
- FIG. 1 a known configuration of a dialyzer is shown.
- blood flows in one end of the dialyzer and through hollow semi-porous or semipermeable fibers toward the blood output side of the dialyzer.
- dialysate flows in an opposite direction, with respect to the blood flow, by entering a dialysate inlet and flowing around or about the semi-porous hollow fibers in which the blood is flowing.
- the dialysate then exits the dialysate outlet.
- the toxins within the blood are removed from the blood via a combination of diffusion, convection, and osmosis processes while the blood is flowing within the fibers and the dialysate is flowing outside the fibers.
- the dialyzer is comprised of a large number of semi-permeable hollow fibers bundled together and placed in a cylindrical jacket as shown. Present day dialysis processes may be classified as: 1) single pass; and 2) sorbent-based.
- Single pass processes require a continuous supply of gallons of fresh and treated water.
- the treated water may be purified by for example, reverse osmosis or distillation.
- the gallons of fresh and treated water are used to create the dialysis fluid, which is discarded after flowing through the dialyzer and collecting the toxins in a single pass through of the dialyzer.
- FIG. 2 shows a schematic/diagram of a cross section of a single semi-permeable fiber that may be used in a dialyzer.
- the blood flows through the hollow lumen within the semi-permeable walls of the fiber.
- the membrane walls have a thickness, which is the difference of the radius R 2 minus the radius R 1 .
- the membrane is semi-permeable and the dialysate, as shown, flows in the opposite direction outside of the semi-permeable fiber.
- Sorbent dialysis differs from single pass dialysis in that the dialysate is regenerated using a series of chemical powders to remove toxins from the dialysate solution.
- spent dialysate from the dialyzer is pumped through the first chemical layer of an enzyme called “urease”.
- the urease catalyzes the breakdown of urea into ammonia and carbon dioxide.
- the dialysate will then pass through a second chemical layer, a cation exchange layer (zirconium phosphate) which absorbs ammonia and other positively charged ions and then through a third, chemical layer, an anion exchange layer (hydrous zirconium oxide) where anions such as phosphate and fluoride are absorbed.
- dialysate is pumped through a fourth layer of activated carbon where organic metabolites such as creatinine are absorbed.
- the filtered dialysate may be passed through a degasser to remove air, carbon dioxide and other gas bubbles that may form or be found in the dialysate.
- the capacity of the zirconium phosphate cation exchange layer to absorb ammonia is limited by the number of sites available to bind ammonia. If the zirconium phosphate layer is depleted, ammonia will remain in the dialysate as it is recycled to the dialyzer. In this case the patient may be at risk of ammonia toxicity. Consequently, the filtered dialysate must be periodically tested or monitored for ammonia concentration.
- a typical dialysis patient generates an excess of about 24 to about 60 grams of urea per day that must be removed from the blood to avoid uremia. Therefore, what is needed is a sorbent for use in dialysis that has the capacity to remove this quantity of urea in a reasonable time frame. Thus, suitable sorbents should have the capacity to remove approximately 2.5 grams per deciliter of dialysate per hour (gm/dl/hr) from the dialysate.
- a urea sorbent is provided that is suitable for use in a sorbent-based dialysis process.
- the sorbent absorbs urea from the dialysate without generating ammonia or carbon dioxide, thereby eliminating the need for monitoring the concentration of ammonia in the dialysate as well as reducing or eliminating the need for de-gassing the dialysate.
- the sorbent is insoluble or substantially insoluble in water and effective to remove urea from dialysate in a pH range of between 4 and 12 and more particularly in a pH range of between about 6 and 8.
- the sorbent is soluble or substantially soluble and effective to bond with urea to remove, or bind urea from a dialysate solution or other aqueous solution.
- a filter for regenerating dialysate includes a sorbent layer comprising a polymer having specific functional groups bonded thereto that interact or react with urea at a pH of between 4 and 12, and more particularly at a pH of between 6 and 8, to remove urea from an aqueous solution.
- the exemplary polymer may be any one of soluble, substantially soluble, insoluble and substantially insoluble in water.
- the exemplary polymer further reacts or interacts with urea while near room temperature or while in a defined temperature range between about 50° F. and 110° F. without releasing ammonia or generating carbon dioxide.
- the reaction product of the polymer and urea may also be any one of soluble, substantially soluble, insoluble and substantially insoluble in water.
- a second filter layer may be used with the exemplary polymer sorbent.
- the second filter layer comprises activated carbon for absorbing organic metabolites from the dialysate or other aqueous solution.
- the filter further includes an anion exchange layer for removing anions from the dialysate.
- a filter for removing urea from an aqueous solution or liquid comprises a sorbent layer or coating.
- the sorbent layer or coating comprises a polymer having specific functional groups bonded thereto.
- the exemplary polymer having specific functional groups bonded thereto interacts or reacts with urea at a pH of between 4 and 12 or a predetermined bounded pH range therebetween (i.e., 3 to 7, 5-9, 6-8, etc.)
- urea is bonded to the exemplary sorbent polymer and removed from an aqueous solution.
- An exemplary polymer may be soluble, substantially soluble, insoluble, or substantially insoluble in water.
- an exemplary polymer reacts with urea at near room temperature or other predetermined temperature range without releasing ammonia or generating carbon dioxide.
- an exemplary polymer reacts or interacts with urea to produce a single reaction product.
- the filter may also include activated carbon for adsorbing and removing other molecules from the aqueous solution.
- the reaction product produced by the reaction or interaction of an exemplary polymer and urea may be soluble, substantially soluble, insoluble, or substantially insoluble in water.
- FIG. 1 illustrates a diagram of a dialyzer
- FIG. 2 illustrates a cross-sectional diagram of a fiber lumen in a dialyzer.
- Glyoxylic acid monohydrate was dissolved in thionyl chloride and the mixture was refluxed for 48 h. Removal of excess thionyl chloride under vacuum gave a gum (glyoxaloyl chloride).
- Polyvinyl alcohol co-ethylene was dissolved in dry DMF (by warming up to 100° C.) and this solution was added (after cooling to about 40° C.) to the previously obtained gum. The mixture was stirred for about 30 min in ice bath and NaH was added. Stirring continued for overnight after removal of the ice bath to obtain a sticky solid which was used for the urea trapping experiments from the dialysis solutions.
- Polyvinyl alcohol co-ethylene was dissolved in DMF (15 ml) by heating the mixture to 100° C. This solution (after cooling to 40° C.) was added to a mixture of pyruvic acid, dicyclohexyl carbodiimide (DCC) and 4-dimethylaminopyridine (DMAP) in dry DMF (15 ml) and the reaction mixture was stirred at room temperature for overnight. The solid obtained was filtered off, washed with water, methanol, dichloromethane (DCM), acetone and ether respectively, dried and used for the urea trapping experiments from the dialysis solutions.
- DCC dicyclohexyl carbodiimide
- DMAP 4-dimethylaminopyridine
- Polyvinyl alcohol co-ethylene was dissolved in DMF (15 ml) by heating the mixture to 100° C. This solution (after cooling to 40° C.) was added to a mixture of glyoxylic acid monohydrate, dicyclohexyl carbodiimide (DCC) and 4-dimethylaminopyridine (DMAP) in dry DMF (15 ml) and the reaction mixture was stirred at room temperature for overnight. The solid obtained was filtered off, washed with water, methanol, dichloromethane (DCM), acetone and ether respectively, dried and used for the urea trapping experiments from the dialysis solutions.
- DCC dicyclohexyl carbodiimide
- DMAP 4-dimethylaminopyridine
- Poly(acrylic acid) was added to a stirred solution of EDC.HCl in distilled water. To this stirred suspension, iso-propylamine was added and the solution was stirred for overnight. The gel obtained was filtered under suction (vacuum pump), washed with water, methanol, dichloromethane (DCM), acetone and ether respectively and dried for one week at room temperature to obtain a thick gel (like a glassy solid), which was used for urea trapping experiments from the dialysis solutions.
- DCM dichloromethane
- Dialysate solutions were analyzed for nitrogen content and the amount of urea in the dialysate was calculated. In some cases, additional urea was added to the solution as indicated in column 2 of each Table (1-5). The polymer reagent was added to the solution in the amount indicated in column 3. The mixture was stirred at room temperature for one hour and filtered. The filtrate was analyzed and the amount of urea removed from the dialysate solution was determined. A minus sign ( ⁇ ) indicates that the results were inconclusive.
- the title identifies the particular polymer reagent tested.
- the first column of each table represents the experiment or run number.
- the second column identifies the particular dialysate solution used for the experiment and whether additional urea was added to the solution.
- the third column indicates the amount of polymer reagent used in the experiment.
- the fifth column identifies the analyzed portion of the reaction mixture (e.g. filtrate). In some cases, a neutralizing agent was added to the filtrate.
- the sixth column (BUN or Blood Urea Nitrogen) provides the concentration of nitrogen in the particular dialysate solution used for the experiment.
- the seventh column gives the amount of urea in the solution.
- the eighth column contains the maximum amount of urea in the solution. In the cases where additional urea was added as indicated in column 2, this number will be higher than the corresponding entry in the sixth column.
- the ninth column is the amount of urea removed from the dialysate solution.
- the first row of each table provides the nitrogen, urea and maximum or total amount of urea present in the dialysate solution used in the experiments.
- vinyl polymers having specific functional groups selected from carboxylic acids, esters and salts, amides, dicarboxylic acids, and esters and salts may be formulated to provide sorbents suitable for use in removing urea from an aqueous solution having a pH from about 6 to 8.
- Other sorbents suitable for removing urea from an aqueous solution having a pH range from 4 to 12 are realizable with various ones of the aforementioned specific functional groups by one of ordinary skill in the art having the information contained herein.
- Such exemplary polymers are substantially insoluble in water and can remove urea from dialysate at a rate of at least 2.5 mg/di/hr. Additionally, such polymers may be soluble, substantially soluble or insoluble in water depending on variations in their manufacture.
- vinyl polymers such as polyvinyl alcohol, polyvinyl alcohol-ethylene co-polymers and polyacrylic acid are reacted with specific functional groups selected from carboxylic acids, carboxylic acid esters, carboxylates, amides, dicarboxylic acids, dicarboxylic acid esters, and dicarboxylates to produce the desired exemplary sorbents.
- Exemplary polymers may be applied to various substrates for use as dialysis sorbents. Such substrates may be organic or inorganic and may include filter paper, plastic or glass beads and other particulate materials that are insoluble in water. The polymers may also be applied to various screens and mesh-type filter materials formed from wire or plastic strands or cloth.
- an exemplary urea sorbent is the use of selective functional groups that can be utilized to make a variety of resultant exemplary sorbents ranging from being soluble, insoluble, a liquid, a gum, an adhesive, a flexible material, a coating as well as a solid or powder.
Abstract
Description
- This application is a divisional of U.S. application Ser. No. 12/479,513, filed Jun. 5, 2009, which claims priority from U.S. Provisional Patent Application No. 61/059,610, filed Jun. 6, 2008 and entitled UREA SORBENT. The entire teachings of the above applications are incorporated herein by reference.
- The following disclosure relates to sorbent materials for separating and/or removing urea from dialysate solutions in sorbent-based dialysis treatment or for separating and/or removing urea from aqueous solutions or liquids in medical related processes or circumstances.
- Hemodialysis is a process by which toxins and other molecules, such as urea, are removed from the blood using a semi-permeable filtering membrane. Typically, the patient's blood and an aqueous solution (i.e., dialysate) are pumped in counter-direction flows in and about hollow, semi-permeable fibers. In
FIG. 1 a known configuration of a dialyzer is shown. Generally, blood flows in one end of the dialyzer and through hollow semi-porous or semipermeable fibers toward the blood output side of the dialyzer. Meanwhile, dialysate flows in an opposite direction, with respect to the blood flow, by entering a dialysate inlet and flowing around or about the semi-porous hollow fibers in which the blood is flowing. The dialysate then exits the dialysate outlet. The toxins within the blood are removed from the blood via a combination of diffusion, convection, and osmosis processes while the blood is flowing within the fibers and the dialysate is flowing outside the fibers. Generally, the dialyzer is comprised of a large number of semi-permeable hollow fibers bundled together and placed in a cylindrical jacket as shown. Present day dialysis processes may be classified as: 1) single pass; and 2) sorbent-based. Single pass processes require a continuous supply of gallons of fresh and treated water. The treated water may be purified by for example, reverse osmosis or distillation. The gallons of fresh and treated water are used to create the dialysis fluid, which is discarded after flowing through the dialyzer and collecting the toxins in a single pass through of the dialyzer. -
FIG. 2 shows a schematic/diagram of a cross section of a single semi-permeable fiber that may be used in a dialyzer. The blood flows through the hollow lumen within the semi-permeable walls of the fiber. The membrane walls have a thickness, which is the difference of the radius R2 minus the radius R1. The membrane is semi-permeable and the dialysate, as shown, flows in the opposite direction outside of the semi-permeable fiber. - Sorbent dialysis differs from single pass dialysis in that the dialysate is regenerated using a series of chemical powders to remove toxins from the dialysate solution. Typically, spent dialysate from the dialyzer is pumped through the first chemical layer of an enzyme called “urease”. The urease catalyzes the breakdown of urea into ammonia and carbon dioxide. The dialysate will then pass through a second chemical layer, a cation exchange layer (zirconium phosphate) which absorbs ammonia and other positively charged ions and then through a third, chemical layer, an anion exchange layer (hydrous zirconium oxide) where anions such as phosphate and fluoride are absorbed. Finally, the dialysate is pumped through a fourth layer of activated carbon where organic metabolites such as creatinine are absorbed. At some point, the filtered dialysate may be passed through a degasser to remove air, carbon dioxide and other gas bubbles that may form or be found in the dialysate.
- The capacity of the zirconium phosphate cation exchange layer to absorb ammonia is limited by the number of sites available to bind ammonia. If the zirconium phosphate layer is depleted, ammonia will remain in the dialysate as it is recycled to the dialyzer. In this case the patient may be at risk of ammonia toxicity. Consequently, the filtered dialysate must be periodically tested or monitored for ammonia concentration.
- A typical dialysis patient generates an excess of about 24 to about 60 grams of urea per day that must be removed from the blood to avoid uremia. Therefore, what is needed is a sorbent for use in dialysis that has the capacity to remove this quantity of urea in a reasonable time frame. Thus, suitable sorbents should have the capacity to remove approximately 2.5 grams per deciliter of dialysate per hour (gm/dl/hr) from the dialysate.
- In one embodiment, a urea sorbent is provided that is suitable for use in a sorbent-based dialysis process. The sorbent absorbs urea from the dialysate without generating ammonia or carbon dioxide, thereby eliminating the need for monitoring the concentration of ammonia in the dialysate as well as reducing or eliminating the need for de-gassing the dialysate. In one variation, the sorbent is insoluble or substantially insoluble in water and effective to remove urea from dialysate in a pH range of between 4 and 12 and more particularly in a pH range of between about 6 and 8. In another embodiment the sorbent is soluble or substantially soluble and effective to bond with urea to remove, or bind urea from a dialysate solution or other aqueous solution.
- In another aspect, a filter for regenerating dialysate includes a sorbent layer comprising a polymer having specific functional groups bonded thereto that interact or react with urea at a pH of between 4 and 12, and more particularly at a pH of between 6 and 8, to remove urea from an aqueous solution. The exemplary polymer may be any one of soluble, substantially soluble, insoluble and substantially insoluble in water. The exemplary polymer further reacts or interacts with urea while near room temperature or while in a defined temperature range between about 50° F. and 110° F. without releasing ammonia or generating carbon dioxide. The reaction product of the polymer and urea may also be any one of soluble, substantially soluble, insoluble and substantially insoluble in water. A second filter layer may be used with the exemplary polymer sorbent. The second filter layer comprises activated carbon for absorbing organic metabolites from the dialysate or other aqueous solution. In one variation, the filter further includes an anion exchange layer for removing anions from the dialysate.
- In another aspect, a filter for removing urea from an aqueous solution or liquid is provided. The filter comprises a sorbent layer or coating. The sorbent layer or coating comprises a polymer having specific functional groups bonded thereto. The exemplary polymer having specific functional groups bonded thereto interacts or reacts with urea at a pH of between 4 and 12 or a predetermined bounded pH range therebetween (i.e., 3 to 7, 5-9, 6-8, etc.) Upon interaction or perhaps a reaction with urea, urea is bonded to the exemplary sorbent polymer and removed from an aqueous solution. An exemplary polymer may be soluble, substantially soluble, insoluble, or substantially insoluble in water. Furthermore, an exemplary polymer reacts with urea at near room temperature or other predetermined temperature range without releasing ammonia or generating carbon dioxide. In various aspects, an exemplary polymer reacts or interacts with urea to produce a single reaction product. The filter may also include activated carbon for adsorbing and removing other molecules from the aqueous solution. The reaction product produced by the reaction or interaction of an exemplary polymer and urea may be soluble, substantially soluble, insoluble, or substantially insoluble in water.
- For a more complete understanding, reference is now made to the following description taken in conjunction with the accompanying Drawings in which:
-
FIG. 1 illustrates a diagram of a dialyzer; and -
FIG. 2 illustrates a cross-sectional diagram of a fiber lumen in a dialyzer. - Referring now to the drawings, the various views and embodiments of exemplary urea sorbents are illustrated and described, and other possible embodiments are described. The figures are not necessarily drawn to scale, and in some instances the drawings have been exaggerated and/or simplified in places for illustrative purposes only. One of ordinary skill in the art will appreciate the many possible applications and variations based on the following examples of possible embodiments.
- Sorbent Preparation:
- 1. Preparation of MPS-IV-048 (Polyvinylglyoxalate)
- 1.1 Reagents
-
Entry Reagent/solvent Amount mmol Equivalent 1 Polyvinyl alcohol 1.000 g 5.0 × 10−3 1 (M. wt. = 205000) (23.3 mmol of alcohol units) 2 Glyoxylic acid 2.144 g 23.30 1 monohydrate (M. wt. = 92) 3 EDC.HC1 (M. wt. = 3.973 g 20.72 0.88 191.71) 4 Distilled water 15 ml - 1.2 Procedure.
- To a stirred solution of glyoxylic acid monohydrate and EDC.HCl in distilled water, polyvinyl alcohol was added stirred the solution for 24 h. Water was evaporated under reduced pressure to obtain a gum, which was used for urea trapping experiments from the dialysis solutions.
- 2. Preparation of MPS-IV-054 (Polyvinylglyoxalate)
- 2.1 Reagents
-
Entry Reagent/solvent Amount mmol Equivalent 1 Polyvinyl alcohol 1.000 g 5.0 × 10−3 1 (M. wt. = 205000) (23.3 mmol of alcohol units) 2 Glyoxylic acid 2.144 g 23.30 1 monohydrate (M. wt. = 92) 3 NaH (M. wt. = 1.538 g 0.846 1.51 24 55-60% in suspension) 4 Dry- N,N- 10 ml Dimethylformamide (DMF) - 2.2 Procedure
- Sodium hydride was added to a cooled (0° C., ice bath) stirred suspension of polyvinyl alcohol in dry DMF and stirring continued for 2-3 min. Glyoxylic acid monohydrate was added to this mixture and the mixture was brought to room temperature after 2 h stirring at 0° C. Stirring continued for overnight. The solid obtained was washed with DCM and used for urea trapping experiments from the dialysis solutions.
- 2.3 Properties
- Melting Point of MPS-IV-054=doesn't melt up to 290 0° C.
Mn=75540; Mw=79736; ρ=1.055 g/cm3 - 3. Preparation of MPS-V-003 (Bis(Polyvinyloxalate))
- 3.1 Reagents
-
Entry Reagent/solvent Amount mmol Equivalent 1 Polyvinyl alcohol 1.000 g 5.0 × 10−3 1 (M. wt. = 205000) (23.3 mmol of alcohol units) 2 Oxalic acid (M. wt. =78) 2.000 g 25.64 1.1 3 EDC.HC1 (M. wt. = 3.973 g 20.72 0.88 191.71) 4 Distilled water 20 ml - 3.2 Procedure
- To a stirred solution of oxalic acid and EDC.HCl in distilled water, polyvinyl alcohol was added stirred the solution for 24 h. Water was evaporated under reduced pressure to obtain a gum, which was used for urea trapping experiments from the dialysis solutions.
- 3.3 Properties
- 4. Preparation of MPS-V-004 (Polyvinylpyruvate)
- 4.1 Reagents
-
Reagent/ Entry solvent Amount mmol Equivalent 1 Polyvinyl 1.000 g 5.0 × 10−3 1 alcohol (M. (23.3 mmol of wt. = 205000) alcohol units) 2 Pyruvic acid 2.10 ml(≡2.226 g) 25.28 1.1 (M. wt. = 88.06; d = 1.06) 3 EDC.HC1 (M. 3.92 g 20.44 0.88 wt. = 191.71) 4 Distilled water 15 ml - 4.2 Procedure
- To a stirred solution of pyruvic acid and EDC.HCl in distilled water, polyvinyl alcohol was added stirred the solution for 24 h. Water was evaporated under reduced pressure to obtain a gum, which was used for urea trapping experiments from the dialysis solutions.
- 4.3 Properties
- 5. Preparation of MPS-V-005 (Polyvinylbezoate 0.33 Polyvinylalcohol 0.66)
- 5.1 Reagents
-
Entry Reagent/solvent Amount mmol Equivalent 1 2.000 g 1.0 × 10−2 (46.6 1 × 10−2 (46.6 1 Polyvinyl mmol of alcohol mmole of alcohol alcohol (M. wt. = units) units) 205000) 2 Benzoyl chloride 2.00 ml(≡2.422 g) 17.23 0.37 (M. wt. = 130.57; d = 1.211) 3 Dry pyridine 25 ml - 5.2 Procedure
- To a stirred, cooled (0° C., ice bath) solution of polyvinyl alcohol in dry pyridine (17 ml), a solution of benzoyl chloride in dry pyridine (8 ml) was added dropwise over a period of 10 min and stirring continued for 24 h with gradual increase in reaction temperature to rt. After 24 h, the pyridine was removed under reduced pressure and by co-evaporation with toluene to obtain a gum which was used for next step. The gum (MPS-V-005) swelled when brought in contact with solvents like ethyl acetate, dichloromethane (DCM), chloroform and methanol.
- 6. Preparation of MPS-Iv-009 (Polyvinylbezoate 0.33 Polyvinylglyoxalate 0.66)
- 6.1 Reagents
-
Entry Reagent/solvent Amount mmol Equivalent 1 MPS-V-005 2.000 g (29.3 mmol of 1 alcohol units) 2 Glyoxylic acid 0.920 g 10.00 0.34 monohydrate (M. wt. = 92) 3 EDC.HC1 (M. wt. = 1.55 g 10.00 0.34 191.71) 4 Distilled water 20 ml - 6.2 Procedure
- A solution of glyoxylic acid monohydrate and EDC.HCl in distilled water was added to MPS-V-005 and the suspension was stirred at room temperature for 48 h. The white ppt obtained was filtered off, dried and used for urea trapping experiments from the dialysis solutions.
- 6.3 Properties
- 7. Preparation of MPS-V-027 (Polyvinylglyoxalate-Ethylene Copolymer)
- 7.1 Reagents
-
Entry Reagent/solvent Amount mmol Equivalent 1 Polyvinyl alcohol- 2.28 g (≡1.838 g of 41.67 1 coethylene (27% polyvinyl alcohol) mmol of ethylene) OH group 2 Glyoxalic acid 4.00 g 43.48 1.04 monohydrate (M. wt. = 92) 3 NaH (M. wt. = 1.200 g 50.00 1.2 24 55-60% in suspension) 4 Thionyl chloride 12 (≡19.572 g) 164.51 3.78 (M. wt. = 118.97, d = 1.613) 5 Dry- N,N - 30 ml Dimethylformamide (DMF) - 7.2 Procedure
- Glyoxylic acid monohydrate was dissolved in thionyl chloride and the mixture was refluxed for 48 h. Removal of excess thionyl chloride under vacuum gave a gum (glyoxaloyl chloride). Polyvinyl alcohol co-ethylene was dissolved in dry DMF (by warming up to 100° C.) and this solution was added (after cooling to about 40° C.) to the previously obtained gum. The mixture was stirred for about 30 min in ice bath and NaH was added. Stirring continued for overnight after removal of the ice bath to obtain a sticky solid which was used for the urea trapping experiments from the dialysis solutions.
- 7.3 Properties
- 8. Preparation of MPS-V-036 (Polyacrylicacid0.9Polyvinylpolyacrylicacid0.1)
- 8.1 Reagents
-
Entry Reagent/solvent Amount mmol Equivalent 1 Poly(acrylic acid) 1.500 g 3.75 × 10−4 1 (M. wt. = 4000000) (20.83 mmol of —COOH units) 2 Polyvinyl alcohol 1.000 g 4.88 × 10−4 0.1 (M. wt. = 205000) (2.27 mmol of —OH units) 3 EDC.HC1 0.479 g 2.49 1.1 eq of —OH (M. wt. = 191.71) groups 4 Distilled water 50 ml - 8.2 Procedure
- Poly (acrylic acid) was added to a stirred solution of EDC.HCl in distilled water. To this stirred suspension, polyvinyl alcohol was added and the solution was stirred for overnight. The gel obtained was filtered under suction (vacuum pump), washed with water, methanol, dichloromethane (DCM), acetone and ether respectively and dried for one week at room temperature to obtain a glassy solid, which was used for urea trapping experiments from the dialysis solutions.
- 8.3 Properties
- 9. Preparation of MPS-V-037 (Polyvinylpyrurate-Ethylene Copolymer)
- 9.1 Reagents
-
Entry Reagent/solvent Amount mmol Equivalent 1 Polyvinyl alcohol - 1.14 g (≡0.909 g of 20.84 1 coethylene (27% polyvinyl alcohol) mmol of ethylene) OH group 2 Pyruvic acid (M. 1.90 ml (≡2.394 g) 27.19 1.3 wt. = 88.06, d = 1.26) 3 DCC (M. wt. 6.450 g 31.26 1.5 206.33) 4 DMAP (M. wt. = 0.382 g 3.13 0.15 122.17) 5 Dry- N,N - 30 ml Dimethylformamide (DMF) - 9.2 Procedure
- Polyvinyl alcohol co-ethylene was dissolved in DMF (15 ml) by heating the mixture to 100° C. This solution (after cooling to 40° C.) was added to a mixture of pyruvic acid, dicyclohexyl carbodiimide (DCC) and 4-dimethylaminopyridine (DMAP) in dry DMF (15 ml) and the reaction mixture was stirred at room temperature for overnight. The solid obtained was filtered off, washed with water, methanol, dichloromethane (DCM), acetone and ether respectively, dried and used for the urea trapping experiments from the dialysis solutions.
- 9.3 Properties
- 10. Preparation of MPS-V-038 (Polyvinylglyoxalate-Ethylene Copolymer)
- 10.1 Reagents
-
Entry Reagent/solvent Amount mmol Equivalent 1 Polyvinyl alcohol- 1.14 g (≡0.909 g of 20.84 1 coethylene (27% polyvinyl alcohol) mmol of ethylene) OH group 2 Glyoxylic acid 2.400 g 26.09 1.25 monohydrate (M. wt. = 92) 3 DCC (M. wt. = 6.450 g 31.26 1.5 206.33) 4 DMAP (M. wt. = 0.382 g 3.13 0.15 122.17) 5 Dry- N,N - 30 ml Dimethylformamide (DMF) - 10.2 Procedure
- Polyvinyl alcohol co-ethylene was dissolved in DMF (15 ml) by heating the mixture to 100° C. This solution (after cooling to 40° C.) was added to a mixture of glyoxylic acid monohydrate, dicyclohexyl carbodiimide (DCC) and 4-dimethylaminopyridine (DMAP) in dry DMF (15 ml) and the reaction mixture was stirred at room temperature for overnight. The solid obtained was filtered off, washed with water, methanol, dichloromethane (DCM), acetone and ether respectively, dried and used for the urea trapping experiments from the dialysis solutions.
- 10.3 Properties
- 11. Preparation of MPS-V-047 (Isopropylaminepolyacrylicamide)
- 11.1 Reagents
-
Entry Reagent/solvent Amount mmol Equivalent 1 Poly(acrylic acid) 1.500 g 3.75 × 10−4 1 (M. wt. = (20.83 mmol of 4000000) —COOH units) 2 iso-Propylamine 0.20 ml 2.33 0.11 (M. wt. = 59.11, (≡0.138 g) d = 0.688) 3 EDC.HC1 (M. 0.479 g 2.49 1.1 eq of wt. = 191.71) —OH groups 4 Distilled water 50 ml - 11.2 Procedure
- Poly(acrylic acid) was added to a stirred solution of EDC.HCl in distilled water. To this stirred suspension, iso-propylamine was added and the solution was stirred for overnight. The gel obtained was filtered under suction (vacuum pump), washed with water, methanol, dichloromethane (DCM), acetone and ether respectively and dried for one week at room temperature to obtain a thick gel (like a glassy solid), which was used for urea trapping experiments from the dialysis solutions.
- 11.3 Properties
- Dialysate solutions were analyzed for nitrogen content and the amount of urea in the dialysate was calculated. In some cases, additional urea was added to the solution as indicated in column 2 of each Table (1-5). The polymer reagent was added to the solution in the amount indicated in column 3. The mixture was stirred at room temperature for one hour and filtered. The filtrate was analyzed and the amount of urea removed from the dialysate solution was determined. A minus sign (−) indicates that the results were inconclusive.
- In the following tables, the title identifies the particular polymer reagent tested. The first column of each table represents the experiment or run number. The second column identifies the particular dialysate solution used for the experiment and whether additional urea was added to the solution. The third column indicates the amount of polymer reagent used in the experiment. The fourth column gives the reaction conditions e.g. time and temperature. (Note: rt=room temperature). It is further understood that room temperature is between about 60 and 78° F. (about 15.56° C. to about 25.56° C.) and that reactions will also occur in a temperature range of between about 50° F. to about 110° F. (about 10° C. to about 43.3° C.). It is believed that reactions will also occur at colder or warmer temperatures, but such reactions have not been specifically tested. The fifth column identifies the analyzed portion of the reaction mixture (e.g. filtrate). In some cases, a neutralizing agent was added to the filtrate. The sixth column (BUN or Blood Urea Nitrogen) provides the concentration of nitrogen in the particular dialysate solution used for the experiment. The seventh column gives the amount of urea in the solution. The eighth column contains the maximum amount of urea in the solution. In the cases where additional urea was added as indicated in column 2, this number will be higher than the corresponding entry in the sixth column. The ninth column is the amount of urea removed from the dialysate solution. The first row of each table provides the nitrogen, urea and maximum or total amount of urea present in the dialysate solution used in the experiments.
-
TABLE 1 MPS-IV-048 Results (in mg/dL) Analyzed Blood Blood Maximum Amount Amount of portion of Urea Urea amount of of urea Soln Reagent Reaction reaction Nitrogen (BUN × urea taken out Entry compn Used (g) condn. mixture (BUN) 2.14) present (mg/dL/h) 1 Soln-3 — — — 7.8 16.692 16.692 — Blank (10 ml) 2 Soln-3 2 rt, 1 h Filtrate 14.6 31.244 16.692 (−) 14.552 (10 ml) (8 mL) 3 Soln-3 13 (0.50 g) rt, 1 h Filtrate 797.2 1706.0 2516.7 810.7 (20 ml) + (10 mL) Urea (0.50 g) -
TABLE 2 MPS-IV-OS4 and MPS-V-009 Results (in mg/dL) Analyzed Blood Blood Maximum Amount Amount of portion of Urea Urea amount of of urea Soln Reagent Reaction reaction Nitrogen (BUN × urea taken out Entry compn Used (g) condn. mixture (BUN) 2.14) present (mg/dL/h) 1 Soln-3 — — — 4 8.56 8.56 — Blank (10 ml) MPS-IV-054 2 Soln-3 2.5 rt, 1 h Filtrate 2227 4765.78 5008.56 242.78 (20 ml) + (5 ml; Urea pH = 10) (0.50 g) 3 Soln-3 2.50 rt, 1 h Filtrate 2523 5399.22 5008.56 (−) 390.66 (10 ml) + (3 ml; Urea pH = 10) + (1.00 g) 2% HCI— (0.4 ml) to neutralize to pH = 7 MPS-V-009 4 Soln-3 1.26 rt, 1 h Filtrate 2563 5484.82 2508.56 (−) 2976.26 (10 ml) + (3 ml; Urea pH = 7) (0.50 g) -
TABLE 3 MPS-V-003 Results (in mg/dL) Analyzed Blood Blood Maximum Amount Amount of portion of Urea Urea amount of of urea Soln Reagent Reaction reaction Nitrogen (BUN × urea taken out Entry compn Used (g) condn. mixture (BUN) 2.14) present (mg/dL/h) 1 Soln-3 — — — 4 8.56 8.56 — (10 ml) Blank 2 Soln-3 rt, 1 h Filtrate 2257 4740 5008 268.3 (20 ml) + (5 mL; Urea pH = 1) (1.00 g) 3 Soln-3 rt, 1 h Filtrate 1527 3267.78 5008 1740.22 (20 ml) + (3 m; Urea pH = 1) + (1.00 g) saturated HCO3 (1 ml) to neutralize to pH = 7 -
TABLE 4 MPS-V-027 and MPS-V-036 Results (in mg/dL) Analyzed Blood Blood Maximum Amount Amount of portion of Urea Urea amount of of urea Soln Reagent Reaction reaction Nitrogen (BUN × urea taken out Entry compn Used (g) condn. mixture (BUN) 2.14) present (mg/dL/h) 1 Soln-4 — — — 88 188.32 188.32 — Blank (9 ml) 2 Soln-4 MPS-V rt, 1 h Filtrate 0 0 2688.32 2688.32 (10 ml) + 036 (2 ml) Urea (residue (pH = 6~7) (0.50 g) after filtration) (2.28 g) 3 Soln-4 MPS-V rt, 1 h Filtrate 1114 2339.4 2688.32 349.3 (10 ml) + 027 (4 ml) Urea (residue (pH = 7~8) (0.50 g) after filtration and washing with MeOH) (4.40 g) -
TABLE 5 MPS-V-037, MPS-V-038 and MPS-V-047 Data for Solution -4 Results (in mg/dL) Analyzed Blood Blood Maximum Amount Amount portion of Urea Urea amount of of urea Soln of Reagent Reaction reaction Nitrogen (BUN × urea taken out Entry compn Used (g) condn. mixture (BUN) 2.14) present (mg/dL/h) 1 Soln-4 — — — 25 53..5 53..5 — Blank (9 ml) 2 Soln-4 2 rt, 1 h Filtrate 0 0 5053.5 5053.5 (20 ml) + (10 ml) Urea (pH-7) (1.00 g) 3 Soln-4 13 (0.50 g) rt, 1 h Filtrate 0 0 2553.5 2553.5 (10 ml) + (10 ml) Urea (pH-7) (0.50 g) 4 Soln-4 MPS-V047 rt, 1 h Filtrate 479 1025.06 2553.5 1528.44 (10 ml) + (2.46 g) (5 ml) Urea (pH = 5) (0.50 g) - As will be appreciated from the foregoing, vinyl polymers having specific functional groups selected from carboxylic acids, esters and salts, amides, dicarboxylic acids, and esters and salts may be formulated to provide sorbents suitable for use in removing urea from an aqueous solution having a pH from about 6 to 8. Other sorbents suitable for removing urea from an aqueous solution having a pH range from 4 to 12 are realizable with various ones of the aforementioned specific functional groups by one of ordinary skill in the art having the information contained herein. Such exemplary polymers are substantially insoluble in water and can remove urea from dialysate at a rate of at least 2.5 mg/di/hr. Additionally, such polymers may be soluble, substantially soluble or insoluble in water depending on variations in their manufacture.
- In some variations of the invention, vinyl polymers such as polyvinyl alcohol, polyvinyl alcohol-ethylene co-polymers and polyacrylic acid are reacted with specific functional groups selected from carboxylic acids, carboxylic acid esters, carboxylates, amides, dicarboxylic acids, dicarboxylic acid esters, and dicarboxylates to produce the desired exemplary sorbents. Exemplary polymers may be applied to various substrates for use as dialysis sorbents. Such substrates may be organic or inorganic and may include filter paper, plastic or glass beads and other particulate materials that are insoluble in water. The polymers may also be applied to various screens and mesh-type filter materials formed from wire or plastic strands or cloth.
- Another advantage of an exemplary urea sorbent is the use of selective functional groups that can be utilized to make a variety of resultant exemplary sorbents ranging from being soluble, insoluble, a liquid, a gum, an adhesive, a flexible material, a coating as well as a solid or powder.
- It will be appreciated by those skilled in the art having the benefit of this disclosure that this urea sorbent provides a viable replacement for prior known dialysis sorbent materials. It should be understood that the drawings and detailed description herein are to be regarded in an illustrative rather than a restrictive manner, and are not intended to be limiting to the particular forms and examples disclosed. On the contrary, included are any further modifications, changes, rearrangements, substitutions, alternatives, design choices, and embodiments apparent to those of ordinary skill in the art, without departing from the spirit and scope hereof, as defined by the following claims. Thus, it is intended that the following claims be interpreted to embrace all such further modifications, changes, rearrangements, substitutions, alternatives, design choices, and embodiments.
Claims (17)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/541,107 US20130008852A1 (en) | 2008-06-06 | 2012-07-03 | Urea sorbent |
US13/953,565 US8672145B2 (en) | 2008-06-06 | 2013-07-29 | Urea sorbent |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5961008P | 2008-06-06 | 2008-06-06 | |
US12/479,513 US8220643B2 (en) | 2008-06-06 | 2009-06-05 | Urea sorbent |
US13/541,107 US20130008852A1 (en) | 2008-06-06 | 2012-07-03 | Urea sorbent |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/479,513 Division US8220643B2 (en) | 2008-06-06 | 2009-06-05 | Urea sorbent |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/953,565 Division US8672145B2 (en) | 2008-06-06 | 2013-07-29 | Urea sorbent |
Publications (1)
Publication Number | Publication Date |
---|---|
US20130008852A1 true US20130008852A1 (en) | 2013-01-10 |
Family
ID=42729831
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/479,513 Expired - Fee Related US8220643B2 (en) | 2008-06-06 | 2009-06-05 | Urea sorbent |
US13/541,107 Abandoned US20130008852A1 (en) | 2008-06-06 | 2012-07-03 | Urea sorbent |
US13/953,565 Expired - Fee Related US8672145B2 (en) | 2008-06-06 | 2013-07-29 | Urea sorbent |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/479,513 Expired - Fee Related US8220643B2 (en) | 2008-06-06 | 2009-06-05 | Urea sorbent |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/953,565 Expired - Fee Related US8672145B2 (en) | 2008-06-06 | 2013-07-29 | Urea sorbent |
Country Status (4)
Country | Link |
---|---|
US (3) | US8220643B2 (en) |
EP (1) | EP2575827A4 (en) |
BR (1) | BR112012031024A2 (en) |
WO (1) | WO2010141949A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014151322A1 (en) | 2013-03-14 | 2014-09-25 | Fresenius Medical Care Holdings, Inc. | Universal portable machine for online hemodiafiltration using regenerated dialysate |
US9433720B2 (en) | 2013-03-14 | 2016-09-06 | Fresenius Medical Care Holdings, Inc. | Universal portable artificial kidney for hemodialysis and peritoneal dialysis |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060217771A1 (en) | 2005-02-07 | 2006-09-28 | Medtronic, Inc. | Potassium monitoring |
US8220643B2 (en) | 2008-06-06 | 2012-07-17 | Fresenius Medical Care Holdings, Inc. | Urea sorbent |
US9399091B2 (en) | 2009-09-30 | 2016-07-26 | Medtronic, Inc. | System and method to regulate ultrafiltration |
US9750862B2 (en) | 2011-04-29 | 2017-09-05 | Medtronic, Inc. | Adaptive system for blood fluid removal |
US9456755B2 (en) | 2011-04-29 | 2016-10-04 | Medtronic, Inc. | Method and device to monitor patients with kidney disease |
US9848778B2 (en) | 2011-04-29 | 2017-12-26 | Medtronic, Inc. | Method and device to monitor patients with kidney disease |
EP2739325B1 (en) | 2011-08-02 | 2017-10-04 | Medtronic, Inc. | Hemodialysis system having a flow path with a controlled compliant volume |
US10857277B2 (en) | 2011-08-16 | 2020-12-08 | Medtronic, Inc. | Modular hemodialysis system |
WO2013103906A1 (en) | 2012-01-04 | 2013-07-11 | Medtronic, Inc. | Multi-staged filtration system for blood fluid removal |
US10905816B2 (en) | 2012-12-10 | 2021-02-02 | Medtronic, Inc. | Sodium management system for hemodialysis |
US11565029B2 (en) | 2013-01-09 | 2023-01-31 | Medtronic, Inc. | Sorbent cartridge with electrodes |
US9707328B2 (en) | 2013-01-09 | 2017-07-18 | Medtronic, Inc. | Sorbent cartridge to measure solute concentrations |
US9713666B2 (en) | 2013-01-09 | 2017-07-25 | Medtronic, Inc. | Recirculating dialysate fluid circuit for blood measurement |
US11154648B2 (en) | 2013-01-09 | 2021-10-26 | Medtronic, Inc. | Fluid circuits for sorbent cartridge with sensors |
US10850016B2 (en) | 2013-02-01 | 2020-12-01 | Medtronic, Inc. | Modular fluid therapy system having jumpered flow paths and systems and methods for cleaning and disinfection |
US9623164B2 (en) | 2013-02-01 | 2017-04-18 | Medtronic, Inc. | Systems and methods for multifunctional volumetric fluid control |
US9526822B2 (en) | 2013-02-01 | 2016-12-27 | Medtronic, Inc. | Sodium and buffer source cartridges for use in a modular controlled compliant flow path |
US10543052B2 (en) | 2013-02-01 | 2020-01-28 | Medtronic, Inc. | Portable dialysis cabinet |
US10010663B2 (en) | 2013-02-01 | 2018-07-03 | Medtronic, Inc. | Fluid circuit for delivery of renal replacement therapies |
US9827361B2 (en) | 2013-02-02 | 2017-11-28 | Medtronic, Inc. | pH buffer measurement system for hemodialysis systems |
US9144640B2 (en) | 2013-02-02 | 2015-09-29 | Medtronic, Inc. | Sorbent cartridge configurations for improved dialysate regeneration |
EP3102107A4 (en) | 2013-11-04 | 2018-02-07 | Medtronic, Inc. | Method and device to manage fluid volumes in the body |
US9895477B2 (en) | 2013-11-26 | 2018-02-20 | Medtronic, Inc. | Detachable module for recharging sorbent materials with optional bypass |
US10052612B2 (en) | 2013-11-26 | 2018-08-21 | Medtronic, Inc. | Zirconium phosphate recharging method and apparatus |
US10004839B2 (en) | 2013-11-26 | 2018-06-26 | Medtronic, Inc. | Multi-use sorbent cartridge |
US10537875B2 (en) | 2013-11-26 | 2020-01-21 | Medtronic, Inc. | Precision recharging of sorbent materials using patient and session data |
US9943780B2 (en) | 2013-11-26 | 2018-04-17 | Medtronic, Inc. | Module for in-line recharging of sorbent materials with optional bypass |
US9884145B2 (en) | 2013-11-26 | 2018-02-06 | Medtronic, Inc. | Parallel modules for in-line recharging of sorbents using alternate duty cycles |
US10595775B2 (en) | 2013-11-27 | 2020-03-24 | Medtronic, Inc. | Precision dialysis monitoring and synchronization system |
KR102033277B1 (en) | 2014-05-29 | 2019-11-08 | 프레제니우스 메디칼 케어 홀딩스 인코퍼레이티드 | Method for treating dialysate, dialysis system, and method for pre-evaluating dialysis patients for treatment with same |
EP3160529B1 (en) | 2014-06-24 | 2019-11-13 | Medtronic Inc. | Replenishing urease in dialysis systems using urease pouches |
WO2015199761A1 (en) * | 2014-06-24 | 2015-12-30 | Medtronic, Inc. | Sorbent pouch |
WO2015199760A1 (en) | 2014-06-24 | 2015-12-30 | Medtronic, Inc. | Replenisihing urease in dialysis systems using a urease introducer |
EP3160534A4 (en) | 2014-06-24 | 2018-03-07 | Medtronic Inc. | Stacked sorbent assembly |
EP3160536A4 (en) | 2014-06-24 | 2018-03-07 | Medtronic Inc. | Reserve zirconium phosphate module for use in sorbent dialysis |
CN106604752B (en) | 2014-06-24 | 2019-07-09 | 美敦力公司 | Urase for supplementing the urase in adsorbent box introduces system |
US10172991B2 (en) | 2014-06-24 | 2019-01-08 | Medtronic, Inc. | Modular dialysate regeneration assembly |
US10098993B2 (en) | 2014-12-10 | 2018-10-16 | Medtronic, Inc. | Sensing and storage system for fluid balance |
US9895479B2 (en) | 2014-12-10 | 2018-02-20 | Medtronic, Inc. | Water management system for use in dialysis |
US10874787B2 (en) | 2014-12-10 | 2020-12-29 | Medtronic, Inc. | Degassing system for dialysis |
US9713665B2 (en) | 2014-12-10 | 2017-07-25 | Medtronic, Inc. | Degassing system for dialysis |
CN105214624B (en) * | 2015-11-02 | 2017-08-04 | 李建中 | A kind of dialyzate adsorption stuffing, its preparation method and application |
WO2017078965A1 (en) | 2015-11-06 | 2017-05-11 | Medtronic, Inc | Dialysis prescription optimization for decreased arrhythmias |
US10391473B1 (en) * | 2016-02-20 | 2019-08-27 | Electric Power Research Institute, Inc. | Polymer-protected sorbent |
US10874790B2 (en) | 2016-08-10 | 2020-12-29 | Medtronic, Inc. | Peritoneal dialysis intracycle osmotic agent adjustment |
US10994064B2 (en) | 2016-08-10 | 2021-05-04 | Medtronic, Inc. | Peritoneal dialysate flow path sensing |
US11013843B2 (en) | 2016-09-09 | 2021-05-25 | Medtronic, Inc. | Peritoneal dialysis fluid testing system |
US10981148B2 (en) | 2016-11-29 | 2021-04-20 | Medtronic, Inc. | Zirconium oxide module conditioning |
JP2019536570A (en) | 2016-12-05 | 2019-12-19 | テマセク ポリテクニックTemasek Polytechnic | Adsorbents for dialysis devices and systems |
US11167070B2 (en) | 2017-01-30 | 2021-11-09 | Medtronic, Inc. | Ganged modular recharging system |
US10960381B2 (en) | 2017-06-15 | 2021-03-30 | Medtronic, Inc. | Zirconium phosphate disinfection recharging and conditioning |
US11278654B2 (en) | 2017-12-07 | 2022-03-22 | Medtronic, Inc. | Pneumatic manifold for a dialysis system |
US11110215B2 (en) | 2018-02-23 | 2021-09-07 | Medtronic, Inc. | Degasser and vent manifolds for dialysis |
CN108653299B (en) * | 2018-06-18 | 2020-11-10 | 江苏纳海生物科技有限公司 | Preparation method of dialysate |
US11213616B2 (en) | 2018-08-24 | 2022-01-04 | Medtronic, Inc. | Recharge solution for zirconium phosphate |
US11806457B2 (en) | 2018-11-16 | 2023-11-07 | Mozarc Medical Us Llc | Peritoneal dialysis adequacy meaurements |
US11806456B2 (en) | 2018-12-10 | 2023-11-07 | Mozarc Medical Us Llc | Precision peritoneal dialysis therapy based on dialysis adequacy measurements |
US11850344B2 (en) | 2021-08-11 | 2023-12-26 | Mozarc Medical Us Llc | Gas bubble sensor |
US11965763B2 (en) | 2021-11-12 | 2024-04-23 | Mozarc Medical Us Llc | Determining fluid flow across rotary pump |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2154983A5 (en) * | 1971-10-01 | 1973-05-18 | Thomson Csf | Artificial kidney machine - uses closed circuit regeneration of small volume of dialysis liquid |
FR2170868B1 (en) * | 1972-02-04 | 1976-07-09 | Rhone Poulenc Ind | |
JPS6359353A (en) * | 1986-08-30 | 1988-03-15 | Res Dev Corp Of Japan | High-molecular urea adsorbent |
US5969052A (en) * | 1996-12-31 | 1999-10-19 | Kimberly Clark Worldwide, Inc. | Temperature sensitive polymers and water-dispersible products containing the polymers |
GB0018467D0 (en) * | 2000-07-27 | 2000-09-13 | Strakan Pharm Ltd | Adhesives |
WO2002040039A2 (en) | 2000-11-20 | 2002-05-23 | Dow Global Technologies Inc. | In vivo use of water absorbent polymers |
US20050233003A1 (en) * | 2001-09-28 | 2005-10-20 | Solubest Ltd. | Hydrophilic dispersions of nanoparticles of inclusion complexes of salicylic acid |
US9346029B2 (en) * | 2005-06-06 | 2016-05-24 | The University Of British Columbia | Polymer-based serum albumin substitute |
DE102006026948B3 (en) * | 2006-06-09 | 2007-12-06 | Rewatronik Gmbh | Heating arrangement for soldering surface-mounted devices comprises a heat storage device for partially storing and releasing heat from a gas stream heated and passed through the heating arrangement and an infrared radiator |
JP2007244393A (en) * | 2007-05-14 | 2007-09-27 | Sumika Agrotech Co Ltd | Method for preparing seedling-raising culture soil, seedling-raising culture soil and set for preparing seedling-raising culture soil |
US8220643B2 (en) | 2008-06-06 | 2012-07-17 | Fresenius Medical Care Holdings, Inc. | Urea sorbent |
-
2009
- 2009-06-05 US US12/479,513 patent/US8220643B2/en not_active Expired - Fee Related
-
2010
- 2010-06-07 WO PCT/US2010/037637 patent/WO2010141949A2/en active Application Filing
- 2010-06-07 EP EP10784232.0A patent/EP2575827A4/en not_active Withdrawn
- 2010-06-07 BR BR112012031024A patent/BR112012031024A2/en not_active IP Right Cessation
-
2012
- 2012-07-03 US US13/541,107 patent/US20130008852A1/en not_active Abandoned
-
2013
- 2013-07-29 US US13/953,565 patent/US8672145B2/en not_active Expired - Fee Related
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014151322A1 (en) | 2013-03-14 | 2014-09-25 | Fresenius Medical Care Holdings, Inc. | Universal portable machine for online hemodiafiltration using regenerated dialysate |
US9433720B2 (en) | 2013-03-14 | 2016-09-06 | Fresenius Medical Care Holdings, Inc. | Universal portable artificial kidney for hemodialysis and peritoneal dialysis |
US10549023B2 (en) | 2013-03-14 | 2020-02-04 | Fresenius Medical Care Holdings, Inc. | Universal portable artificial kidney for hemodialysis and peritoneal dialysis |
US10792414B2 (en) | 2013-03-14 | 2020-10-06 | Fresenius Medical Care Holdings, Inc. | Universal portable machine for online hemodiafiltration using regenerated dialysate |
EP3777914A1 (en) | 2013-03-14 | 2021-02-17 | Fresenius Medical Care Holdings, Inc. | Universal portable machine for online hemodiafiltration using regenerated dialysate |
US11246972B2 (en) | 2013-03-14 | 2022-02-15 | Fresenius Medical Care Holdings, Inc. | Universal portable machine for online hemodiafiltration using regenerated dialysate |
US11701459B2 (en) | 2013-03-14 | 2023-07-18 | Fresenius Medical Care Holdings, Inc. | Universal portable artificial kidney for hemodialysis and peritoneal dialysis |
Also Published As
Publication number | Publication date |
---|---|
EP2575827A4 (en) | 2015-03-18 |
WO2010141949A2 (en) | 2010-12-09 |
BR112012031024A2 (en) | 2016-10-25 |
WO2010141949A3 (en) | 2011-04-21 |
US8672145B2 (en) | 2014-03-18 |
US8220643B2 (en) | 2012-07-17 |
EP2575827A2 (en) | 2013-04-10 |
US20100230346A1 (en) | 2010-09-16 |
US20130313188A1 (en) | 2013-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8672145B2 (en) | Urea sorbent | |
EP2543429B1 (en) | Macromolecular water-treatment membrane and manufacturing method therefor | |
US11560438B2 (en) | Porous polymeric cellulose prepared via cellulose crosslinking | |
CN102698614B (en) | Tubular nanofiltration membrane with multi-layer structure and preparation method thereof | |
SG193905A1 (en) | Filter medium for water treatment filter and production method thereof | |
CN100584879C (en) | Method for preparing imidazole modified styrene type macroporous adsorption resin | |
CN111471033B (en) | Device and method for preparing cyclic carbonate by integrating absorption separation and catalytic reaction | |
CA3032532C (en) | Material for blood purification | |
CN102086165A (en) | Application of Pd catalyst in hydrogenation process for producing doxycycline | |
CN1011201B (en) | Alkali resistant hyperfiltration membrane | |
CN113122938B (en) | Preparation method and application of MOFs-containing chitosan/polyvinyl alcohol nanofiber membrane | |
JP2013528103A (en) | Urea adsorbent | |
JP2023502995A (en) | Porous Membrane Containing Adsorbent Particles for Improved Urea Capture | |
JP2000290829A (en) | Anion exchange fiber and its production | |
CN1125635A (en) | Modified polysulphone super-filter membrane and its preparation and application | |
KR100637683B1 (en) | Biodegradable molecular imprinted polymer | |
CN117358068B (en) | CO (carbon monoxide) 2 Separation composite membrane and preparation method thereof | |
CN111635536B (en) | Graphene oxide loaded renewable antibacterial polypropylene material and preparation method thereof | |
US9345997B2 (en) | Active polymeric filters | |
JPS627419A (en) | Separation of sulfur oxide gas | |
CN103990492A (en) | Composite catalyst for dehydration condensation reaction and preparation method thereof | |
CN116371083A (en) | Preparation method of non-woven air filtering material with formaldehyde removing function | |
JP2011206671A (en) | Carbon dioxide adsorbent composed of cyclic guanidine compound, and method for producing cyclic guanidine compound | |
CN116510522A (en) | Modified anion exchange membrane for monovalent selective electrodialysis, modification method and application | |
JP2008079752A (en) | Adsorption carrier and its production method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: NATIONAL QUALITY CARE, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:EISEN, MORIS S.;REEL/FRAME:028485/0399 Effective date: 20090812 Owner name: FRESENIUS MEDICAL CARE HOLDINGS, INC., MASSACHUSET Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:FRESENIUS USA, INC.;REEL/FRAME:028485/0427 Effective date: 20100722 Owner name: FRESENIUS USA, INC., MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NATIONAL QUALITY CARE, INC.;REEL/FRAME:028485/0386 Effective date: 20100319 Owner name: THE TECHNION RESEARCH AND DEVELOPMENT FOUNDATION, Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:EISEN, MORIS S.;REEL/FRAME:028485/0399 Effective date: 20090812 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |